I’m catching up on my reading now, so passing on links to a number of important studies , some ongoing , published in late 2010, including: Public Citizen Pharmaceutical Industry Is Biggest Defrauder of the Federal Government Under the False Claims Act MSF/Doctors Without Borders Access to Essential Medicines: Ten Stories That Mattered in 2010 [...]
Archive for the ‘Consumer Protection’ Category
Another drug price story that defies logic
Posted in Access to Medicines, Consumer Protection, Economics of Health Care, Ethics, Health Care Marketing, Health Insurance on 15 December 2010 | Leave a Comment »
A friend recently shared this personal story with me, in the hopes that it will inspire people to demand price controls on drugs, as well as an end to the Rx profiteering by insurance companies. This is a story about a commonly-prescribed generic drug, levothyroxine, used for hypothyroidism and other thyroid conditions. The fact that [...]
Selling Sickness Conference
Posted in Access to Medicines, Consumer Protection, Economics of Health Care, Ethics, Global Health, Health Care Marketing, Promotions on 11 October 2010 | 1 Comment »
The first international “Selling Sickness” Conference held October 7-8 in Amsterdam drew some 200 participants from around the globe to discuss the issues and trends in marketing of prescription drugs. While most attendees were from Europe, all regions of the world were represented at the event. Slide shows of the presentations, along with a list [...]
Conference Time
Posted in Consumer Protection, Economics of Health Care, Ethics, Global Health, Health Care Marketing, Health Disparities, Healthcare Inequalities, Language Access, Language Services on 26 September 2010 | 3 Comments »
Many important conferences are scheduled from September to the end of the year. Last week I was fortunate to be able to attend the second annual meeting of the Consortium of Universities for Global Health at the University of Washington here in Seattle. I’ll report on that later. Some other notable conferences, including those in [...]
More Health Headlines of Note
Posted in Access to Medicines, Assistance, Consumer Protection, Discrimination, Economics of Health Care, Ethics, Health Care Marketing on 3 June 2010 | Leave a Comment »
From Pharmalot, May 24, 2010: Wyeth Marketing Targeted Blacks Illegally: Lawsuit A pair of former hospital sales reps filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for use with other organs and targeted African-Americans, even though this is a high-risk patient group, according to [...]
In the News, and Why it Matters
Posted in Access to Medicines, Assistance, Cause Marketing, Consumer Protection, Cord Blood, Economics of Health Care, Ethics, Health Care Marketing, National Marrow Donor Program, Promotions on 1 June 2010 | Leave a Comment »
These news items have as yet not received much attention, but highlight health issues of concern: Asda to sell cancer drugs at cost price Asda is to sell cancer drugs on a not-for-profit basis while thousands of NHS patients continue to be denied medicines that are deemed too expensive. The supermarket giant called on other [...]
